Track the 메지온 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 메지온 has logged 35 public disclosures. The latest transaction was filed on 14 July 2026 (Purchase). Among the most active insiders: 노성일. The full history is free.
33
Insider Decl.
n/a
Thresholds
n/a
13 ops.
Buy Volume
n/a
4 ops.
Sell Volume
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
메지온 is a company operating in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative treatments for various diseases.